153 related articles for article (PubMed ID: 34012039)
1. Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.
Murakami N; Asami Y; Yoshida H; Takayanagi D; Hirose S; Kuno I; Takahashi K; Matsuda M; Shimada Y; Yamano S; Sunami K; Honda T; Nakahara T; Watanabe T; Okuma K; Kuroda T; Kohno T; Kato T; Shiraishi K; Itami J
Sci Rep; 2021 May; 11(1):10567. PubMed ID: 34012039
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy.
Watanabe T; Nanamiya H; Kojima M; Nomura S; Furukawa S; Soeda S; Tanaka D; Isogai T; Imai JI; Watanabe S; Fujimori K
Sci Rep; 2020 Oct; 10(1):18734. PubMed ID: 33127935
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
4. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
5. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
7. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
Chen SW; Liang JA; Yang SN; Lin FJ
Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
[TBL] [Abstract][Full Text] [Related]
8. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
9. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
[TBL] [Abstract][Full Text] [Related]
11. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
Savino L; Borruto F; Comparetto C; Massi GB
Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
[TBL] [Abstract][Full Text] [Related]
12. Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity.
Zhang G; He F; Miao L; Wu H; Zhang Y; Fu C
Jpn J Clin Oncol; 2021 May; 51(6):905-910. PubMed ID: 33822980
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
[No Abstract] [Full Text] [Related]
14. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy.
Yamamoto T; Umezawa R; Tokunaga H; Kubozono M; Kozumi M; Takahashi N; Matsushita H; Kadoya N; Ito K; Sato K; Tsuji K; Shimada M; Jingu K
J Radiat Res; 2020 May; 61(3):470-478. PubMed ID: 32100833
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
[TBL] [Abstract][Full Text] [Related]
17. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
18. Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.
Tsuchida K; Murakami N; Kato T; Okuma K; Okamoto H; Kashihara T; Takahashi K; Inaba K; Igaki H; Nakayama Y; Nakano T; Itami J
J Radiat Res; 2019 Oct; 60(5):650-657. PubMed ID: 31251358
[TBL] [Abstract][Full Text] [Related]
19. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes of patients with stage IA2 cervical cancer treated with radical hysterectomy.
Mahawerawat S; Charoenkwan K; Srisomboon J; Khunamornpong S; Suprasert P; Sae-Teng CT
Asian Pac J Cancer Prev; 2013; 14(9):5375-8. PubMed ID: 24175829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]